<DOC>
	<DOCNO>NCT01143948</DOCNO>
	<brief_summary>Liver disease important cause death type 2 diabetes . In population-based Verona Diabetes Study cirrhosis fourth lead cause death account 4.4 % diabetes-related death . In another prospective cohort study , cirrhosis account 12.5 % deaths patient diabetes . In Egypt hepatitis C virus common cirrhosis prevalence 9.8 % population great burden national health care bill . Patients cirrhosis &amp; type 2 diabetes mellitus always show hospital ward without clear consensus best management hyperglycemia .</brief_summary>
	<brief_title>Various Insulin Regimens Diabetic Inpatients With Cirrhosis Trial</brief_title>
	<detailed_description>Best management hyperglycemia non-intensive care unit Cirrhotic patient type 2 diabetes different insulin regimens either slide scale regular insulin basal bolus insulin use NPH &amp; regular insulin Glargine &amp; Glulisine .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Hospitalized type 2 Diabetes Mellitus liver cirrhosis Entry blood glucose ( fast random ) great 180 mg % Type 1 Diabetes Mellitus Pregnancy Steroids : prednisone great 7.5mg/day equivalent Serum Creatinine &gt; 3 mg/dl Patients intensive care unit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Insulin</keyword>
	<keyword>Inpatient</keyword>
</DOC>